Picture of MegaMD Co logo

133750 MegaMD Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual income statement for MegaMD Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue69,20275,32880,37482,44079,435
Cost of Revenue
Gross Profit40,45447,31748,60150,81448,891
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses71,31573,79681,21976,18674,620
Operating Profit-2,1141,532-8456,2534,815
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1,5182,0852,6077,2687,935
Provision for Income Taxes
Net Income After Taxes-2,3181,1278054,8856,650
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-2,8161,1104134,8976,650
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-2,8161,1104134,8976,650
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-89.461.9-1.29256411
Dividends per Share

Or unlock with your email

Or unlock with your email